General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Edwards(SIGNIFICANT), Eli Lilly and Company(SIGNIFICANT), Merck & Co., Inc.(SIGNIFICANT), VADovations(NONE), Janssen Pharmaceuticals, Inc(SIGNIFICANT), NGMBio(SIGNIFICANT), ShouTi(SIGNIFICANT), BridgeBio Pharmacy(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Medtronic(SIGNIFICANT), AstraZeneca Pharmaceuticals(SIGNIFICANT), Corvia(SIGNIFICANT), Tenax(SIGNIFICANT), NIH/NHLBI(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), DoD(SIGNIFICANT), Axon(SIGNIFICANT), Rivus(SIGNIFICANT)

View Full Disclosure